Contribution: Industrial Research Assistance Program – Contributions to Organizations
Consortium MEDTEQ+
$690,000.00
Clinical evaluation of swabs for COVID-19 testing
FY 2020-21 · 2020-08-15
Summary
Coordination by MEDTEQ+ for the clinical evaluation of novel nasopharyngeal swabs manufactured by Canadian companies for COVID-19 testing,
Department
Program
Industrial Research Assistance Program – Contributions to OrganizationsIndustrial Research Assistance Program-Contributions to Organizations (linked with high confidence)
Recipient
Location
Montreal|Montreal, Quebec, Canada
Recipient Type
Not-for-profit organization or charity
Business Number
822206934
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-08-15 | 2020-21 | $740,000.00 |
| 1 | 2020-08-15 | 2020-21 | $740,000.00 |
| 2 | 2020-08-15 | 2020-21 | $740,000.00 |
| 3 | 2020-08-15 | 2020-21 | $740,000.00 |
| 4 | 2020-08-15 | 2020-21 | $740,000.00 |
| 5 | 2020-08-15 | 2020-21 | $690,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days. The total amended value is -50,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 92 jours. La valeur totale des modifications est de - 50 000 dollars.
Agreement End Date
2022-10-31
Agreement Number
959030
Agreement Start Date
2020-08-15
Agreement Title
Clinical evaluation of swabs for COVID-19 testing
Agreement Title (French)
Évaluation clinique d'écouvillons pour les tests de la COVID-19
Agreement Type
Contribution
Agreement Value
$690,000.00
Amendment Date
2022-10-11
Amendment Number
5
Coverage
IRAP Contributions to Organizations projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux organismes stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Coordination by MEDTEQ+ for the clinical evaluation of novel nasopharyngeal swabs manufactured by Canadian companies for COVID-19 testing,
Description (French)
Coordination par MEDTEQ+ pour l'évaluation clinique de nouveaux écouvillons nasopharyngés fabriqués par des entreprises canadiennes pour les tests de la COVID-19.
Expected Results
The purpose of IRAP Contributions to Organizations is to support Organizations in building and integrating the innovation capacity in Canada for the benefit of Firms in Canada, primarily SMEs and to support Organizations in providing innovation assistance services to SMEs in Canada.
Expected Results (French)
Le PARI, par le biais des Contributions aux organismes, vise à soutenir les organismes en les aidant à construire et à intégrer leur capacité d’innovation au Canada au bénéfice des entreprises canadiennes, et plus particulièrement des PME et à aider les organismes à offrir des services d’aide à l’innovation aux PME au Canada.
Federal Riding
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding (French)
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number
24077
NAICS Code
81399
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Organizations
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux organismes
Program Purpose
The purpose of IRAP Contributions to Organizations is to support Organizations in building and integrating the innovation capacity in Canada for the benefit of Firms in Canada, primarily SMEs and to support Organizations in providing innovation assistance services to SMEs in Canada.
Program Purpose (French)
Le PARI, par le biais des Contributions aux organismes, vise à soutenir les organismes en les aidant à construire et à intégrer leur capacité d’innovation au Canada au bénéfice des entreprises canadiennes, et plus particulièrement des PME et à aider les organismes à offrir des services d’aide à l’innovation aux PME au Canada.
Recipient Business Number
822206934
Recipient City
Montreal|Montreal
Recipient Country
CA
Recipient Legal Name
Consortium MEDTEQ+
Recipient Operating Name
MEDTEQ+ L'innovation pour la santé
Recipient Postal Code
H3C 3X6
Recipient Province or Territory
QC
Recipient Type
N
Reference Number
172-2020-2021-Q3-959030
